Emergent BioSolutions Inc. — Director's Dealing 2016

May 16, 2016

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Emergent BioSolutions Inc. (EBS)
CIK: 0001367644
Period of Report: 2016-05-12

Reporting Person: Hauer Jerome M (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2016-05-12	Common Stock	M	4700	$27.93	Acquired	18800	Direct
2016-05-12	Common Stock	S	4700	$38.50	Disposed	14100	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2016-05-12	Stock Option	$27.93	M	4700	Disposed	2022-01-21	Common Stock (4700)	Direct

Footnotes

F1: Consists of an option granted under the company's stock incentive plan on January 22, 2015.

F2: The options vest in three equal installments in January 2016, 2017 and 2018.